HPV 6, 11, 42/Combo detection doesn't ID CIN 2+, 3+ risk

HPV 6, 11, 42/Combo detection doesn't ID CIN 2+, 3+ risk

(HealthDay)—Detection of human papillomavirus (HPV) 6, 11, 42 or combination infections does not identify increased three-year risk of cervical precancer, according to a study published in the January issue of Obstetrics & Gynecology.

Philip E. Castle, Ph.D., M.P.H., from the Albert Einstein College of Medicine in New York City, and colleagues used data from the New Mexico Human Papillomavirus Pap Registry for a stratified sample of 59,644 residual cervical cytology specimens that underwent HPV genotyping from a population of 379,000 cytology specimens. The three-year cumulative incidence of cervical intraepithelial neoplasia grade 2 or more severe (CIN 2+) and grade 3 or more severe (CIN 3+) was assessed after detection of 581 single or multiple infections of HPV 6, 11, or 42.

The researchers found that there was a 0.8 percent overall prevalence of a single of HPV 6, 11, or 42. After 581 HPV 6, 11, 42, or combinations infections, the three-year risk of CIN 2+ and CIN 3+ were 0.4 and 0.0 percent, respectively. In comparison, after a negative HPV result (27,522 cytologic results), the three-year risks of CIN 2+ and CIN 3+ were 0.2 and 0.1 percent, respectively.

"Testing for HPV 6, 11, 42, or combinations of those types should be discontinued because it has no proven benefit to patients," the authors write.

Roche Molecular Systems provided the Genotyping Test and equipment to automate the HPV genotyping assays. Two authors disclosed financial ties to pharmaceutical and biotechnology companies, including Roche.

More information: Full Text (subscription or payment may be required)

Related Stories

Recommended for you

German woman, 65, gives birth to quadruplets

date May 23, 2015

A 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticized by medical professionals because of her age, RTL television said Saturday.

More evidence C-sections riskier for moms

date May 20, 2015

(HealthDay)—Women who deliver their first baby by cesarean section are more likely to need blood transfusions and be admitted to intensive care units than women who opt for a vaginal delivery, U.S. health ...

Meds offer slight symptom relief in overactive bladder

date May 20, 2015

(HealthDay)—For women with overactive bladder, medications delivered as a daily dose correlate with small reductions in urge incontinence episodes and voiding, according to a review published online May ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.